Publications (1)2.43 Total impact
-
Article: Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile.
[show abstract] [hide abstract]
ABSTRACT: Three commercial molecular assays were evaluated for toxigenic Clostridium difficile detection in stools. As compared to toxigenic culture, BD GeneOhm Cdiff (BD Diagnostics), XPert C. difficile (Cepheid) and illumigene C. difficile (Meridian Bioscience) demonstrated respectively a sensitivity of 95.5%, 97.8% and 86.7% and a specificity of 97.9%, 97.9% and 100%.Journal of microbiological methods 04/2012; 90(2):83-5. · 2.43 Impact Factor
Top Journals
Institutions
-
2012
-
Assistance Publique – Hôpitaux de Paris
Paris, Ile-de-France, France
-
